Brind.

Lifeward entered a strategic financing framework with Oramed Pharmaceuticals on July 1, 2026, and filed the necessary reports with the U.S. SEC.

1 report, 1 independent Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Lifeward entered a strategic financing framework with Oramed Pharmaceuticals on July 1, 2026, and filed the necessary reports with the U.S. SEC.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped